Stocks and Investing
Stocks and Investing
Mon, May 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mason Carrico Reiterated (VCYT) at Buy and Held Target at $30 on, May 8th, 2023
Mason Carrico of Stephens & Co., Reiterated "Veracyte, Inc." (VCYT) at Buy and Held Target at $30 on, May 8th, 2023.
Mason has made no other calls on VCYT in the last 4 months.
There are 2 other peers that have a rating on VCYT. Out of the 2 peers that are also analyzing VCYT, 1 agrees with Mason's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Cooper of "Raymond James" Downgraded from Buy to Hold on, Wednesday, January 18th, 2023
This is the rating of the analyst that currently disagrees with Mason
- Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $34 on, Thursday, February 23rd, 2023
Contributing Sources